Skip to main content

Market Overview

12 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Share:

Gainers

  • Nuvectra, Inc. (NASDAQ: NVTR) stock increased by 30.8% to $1.87 during Tuesday's pre-market session. The market cap seems to be at $30.7 million.
  • Celyad, Inc. (NASDAQ: CYAD) shares increased by 4.7% to $13.17. The market cap stands at $422.5 million.
  • Endo International, Inc. (NASDAQ: ENDP) shares increased by 4.1% to $3.03. The market value of their outstanding shares is at $644.6 million. The most recent rating by Morgan Stanley, on July 15, is at Underweight, with a price target of $3.00.
  • Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares rose 4.0% to $2.35. The market cap stands at $42.3 million.
  • Elanco Animal Health, Inc. (NYSE: ELAN) stock increased by 3.9% to $26.90. The market cap seems to be at $12.2 billion. According to the most recent rating by Bank of America, on August 26, the current rating is at Neutral.
  • Mallinckrodt, Inc. (NYSE: MNK) shares moved upwards by 3.2% to $4.35. The most recent rating by Barclays, on June 11, is at Equal-Weight, with a price target of $11.00.
  • Teva Pharmaceutical Indus, Inc. (NYSE: TEVA) shares rose 3.0% to $7.65. The market cap stands at $7.3 billion. The most recent rating by BMO Capital, on August 09, is at Market Perform, with a price target of $9.00.
  • Intrexon, Inc. (NASDAQ: XON) stock moved upwards by 2.4% to $6.00. The market cap stands at $1.8 billion. The most recent rating by Bank of America, on August 09, is at Underperform, with a price target of $6.00.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) stock rose 2.3% to $1.36. The market cap seems to be at $209.3 million. The most recent rating by Alliance Global Partners, on August 01, is at Neutral, with a price target of $0.40.

 

Losers

  • DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) shares plummeted 9.2% to $0.70 during Tuesday's pre-market session.
  • Cardinal Health, Inc. (NYSE: CAH) shares declined 1.3% to $43.29. According to the most recent rating by Argus Research, on August 27, the current rating is at Hold.
  • Histogenics, Inc. (NASDAQ: HSGX) stock decreased by 1.1% to $0.21. The market value of their outstanding shares is at $52.8 million.
 

Related Articles (CAH + CYAD)

View Comments and Join the Discussion!

Posted-In: Healthcare StocksPre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com